Publications by authors named "Lepage Come"

Claim this Profile
E
Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
Eric Assenat, Meher Ben Abdelghani, Sophie Gourgou, Hervé Perrier, Faiza Khemissa Akouz

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of cancer survivors' extra risk of noncancer mortality on net survival estimation.
Laura Botta, Riccardo Capocaccia, Alice Bernasconi, Silvia Rossi, Jaume Galceran, Come Lepage

Am J Epidemiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning on Histologic Slides Accurately Predicts Consensus Molecular Subtypes and Spatial Heterogeneity in Colon Cancer.
Jean-Eudes Le Douget, Paul Jacob, Côme Lepage, Claire Gallois, Marine Sroussi

Mod Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological Classification Changes and Incidence of Early-Onset Colorectal Cancer.
Valérie Jooste, Jean-Baptiste Nousbaum, Arnaud Alves, Anne-Sophie Woronoff, Guy Launoy

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between induced organ atrophy assessed by artificial intelligence-generated automatic segmentation and efficacy of bevacizumab in combination with chemotherapy in metastatic colorectal cancer.
Malik Laich, Mathias Brugel, Pierre Henri Conze, Marwan Abbas, Mohammed Ben Abdelghanie

Cancer Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI).
David Tougeron, Laurent Mineur, Aziz Zaanan, Melissa Kadi, Catherine Poisson Ligeza

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.
Elisabeth Sophie Bergen, Clémence Canton, Mathieu Boulin, Karine Le Malicot, Jaafar Bennouna

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of Multiple Endocrine Neoplasia Type 1 patients: A mixed methods systematic review.
Vignon Salomé, Journé Antoine, Lepage Côme, Goudet Pierre, Binquet Christine

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example.
Mikail Nourredine, Antoine Gavoille, Côme Lepage, Behrouz Kassai-Koupai, Michel Cucherat

Stat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
Eric Assenat, Meher Ben Abdelghani, Sophie Gourgou, Hervé Perrier, Faiza Khemissa Akouz

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901).
William B Robb, Julie Veziant, Laetitia Dahan, Françoise Mornex, Emilie Barbier

Eur J Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.
Claire Gallois, Marine Sroussi, Thierry André, Sophie Mouillet-Richard, Natacha Agueeff

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial).
Thierry Lecomte, Bruno Giraudeau, Jean-Marc Phelip, Christophe Tournigand, Michel Ducreux

Dig Liver Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized clinical trial evaluating the impact on survival and quality of life of Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).
Jaume Capdevila, Virginia Pubul, Urbano Anido, Thomas Walter, Javier Molina-Cerrillo, Come Lepage

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.
David Tougeron, Christophe Louvet, Jérôme Desramé, Ludovic Evesque, Antoine Angelergues

Commun Med (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer.
Valérie Jooste, Côme Lepage, Sylvain Manfredi, Anne-Marie Bouvier

Dig Liver Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE.
Chloé Buchalet, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Nathalie Bonichon-Lamichhane

Dig Liver Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.
Victoire Dabout, Laurent Mineur, David Tougeron, Karine Le Malicot, Claire Gallois

Clin Res Hepatol Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer.
Jean-David Fumet, Nicolas Roussot, Aurélie Bertaut, Emeric Limagne, Marion Thibaudin, Come Lepage

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Targeted therapies and immunotherapy: Positioning in the field of innovation and challenges for the therapeutic decision-making process].
Carole El Chami, Nicolas Meunier-Beillard, Christine Binquet, Côme Lepage, Catherine Lejeune

Bull Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.
Laura Botta, Riccardo Capocaccia, Alice Bernasconi, Silvia Rossi, Jaume Galceran, Come Lepage

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
Aurelien Fosse, Julien Hadoux, Paul Girot, Amandine Beron, Pauline Afchain, Come Lepage

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer.
Emeric Boisteau, Laetitia Dahan, Nicolas Williet, Karine Le Malicot, Jérôme Desramé

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant radiotherapy combined with fluorouracil-cisplatin plus cetuximab in operable, locally advanced esophageal carcinoma: Results of a phase I-II trial (FFCD-0505/PRODIGE-3).
Bernadette de Rauglaudre, Guillaume Piessen, Marine Jary, Karine Le Malicot, Antoine Adenis

Clin Transl Radiat Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology.
Elodie Martin, Karine Le Malicot, Catherine Guérin-Charbonnel, François Bocquet, Olivier Bouché

Curr Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis